As of Nov 17
| 0.00 / 0.00%|
The 24 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 13.50, with a high estimate of 38.00 and a low estimate of 6.00. The median estimate represents a -2.46% decrease from the last price of 13.84.
The current consensus among 30 polled investment analysts is to Hold stock in Teva Pharmaceutical. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.